ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
COVID-19 in lymphangioleiomyomatosis an international study of outcomes and impact of mechanistic target of rapamycin inhibition. [Carta] (2022)
Baldi, Bruno Guedes; Radzikowska, Elzbieta; Cottin, Vincent; Dilling, Daniel F; Ataya, Ali; Carvalho, Carlos Roberto Ribeiro De ; Harari, Sergio; Koslow, Matthew; Grutters, Jan C; Inoue, Yoshikazu
Source: Chest. Unidade: FM
Subjects: RETRATAÇÃO, SISTEMA RESPIRATÓRIO, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BALDI, Bruno Guedes et al. COVID-19 in lymphangioleiomyomatosis an international study of outcomes and impact of mechanistic target of rapamycin inhibition. [Carta]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2021.12.640. Acesso em: 09 nov. 2024. , 2022
APA
Baldi, B. G., Radzikowska, E., Cottin, V., Dilling, D. F., Ataya, A., Carvalho, C. R. R. D., et al. (2022). COVID-19 in lymphangioleiomyomatosis an international study of outcomes and impact of mechanistic target of rapamycin inhibition. [Carta]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2021.12.640
NLM
Baldi BG, Radzikowska E, Cottin V, Dilling DF, Ataya A, Carvalho CRRD, Harari S, Koslow M, Grutters JC, Inoue Y. COVID-19 in lymphangioleiomyomatosis an international study of outcomes and impact of mechanistic target of rapamycin inhibition. [Carta] [Internet]. Chest. 2022 ; 161( 6): 1589-1593.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2021.12.640
Vancouver
Baldi BG, Radzikowska E, Cottin V, Dilling DF, Ataya A, Carvalho CRRD, Harari S, Koslow M, Grutters JC, Inoue Y. COVID-19 in lymphangioleiomyomatosis an international study of outcomes and impact of mechanistic target of rapamycin inhibition. [Carta] [Internet]. Chest. 2022 ; 161( 6): 1589-1593.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2021.12.640
Artigo de periodico
Effects of CPAP on Metabolic Syndrome in Patients With OSA A Randomized Trial (2022)
Giampa, Sara Q. C; Furlan, Sofia F; Freitas, Lunara S; Macedo, Thiago A; Lebkuchen, Adriana; Cardozo, Karina H. M; Carvalho, Valdemir M; Martins, Franco C; Lorenzi Filho, Geraldo ; Drager, Luciano Ferreira
Source: Chest. Unidade: FM
Subjects: RESISTÊNCIA À INSULINA, ESTUDOS RETROSPECTIVOS, APNEIA DO SONO TIPO OBSTRUTIVA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIAMPA, Sara Q. C et al. Effects of CPAP on Metabolic Syndrome in Patients With OSA A Randomized Trial. Chest, v. 161, n. 5, p. 1370-1381, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2021.12.669. Acesso em: 09 nov. 2024.
APA
Giampa, S. Q. C., Furlan, S. F., Freitas, L. S., Macedo, T. A., Lebkuchen, A., Cardozo, K. H. M., et al. (2022). Effects of CPAP on Metabolic Syndrome in Patients With OSA A Randomized Trial. Chest, 161( 5), 1370-1381. doi:10.1016/j.chest.2021.12.669
NLM
Giampa SQC, Furlan SF, Freitas LS, Macedo TA, Lebkuchen A, Cardozo KHM, Carvalho VM, Martins FC, Lorenzi Filho G, Drager LF. Effects of CPAP on Metabolic Syndrome in Patients With OSA A Randomized Trial [Internet]. Chest. 2022 ; 161( 5): 1370-1381.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2021.12.669
Vancouver
Giampa SQC, Furlan SF, Freitas LS, Macedo TA, Lebkuchen A, Cardozo KHM, Carvalho VM, Martins FC, Lorenzi Filho G, Drager LF. Effects of CPAP on Metabolic Syndrome in Patients With OSA A Randomized Trial [Internet]. Chest. 2022 ; 161( 5): 1370-1381.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2021.12.669
Artigo de periodico
Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents (2020)
Mclaughlin, Vallerie V; Channick, Richard; Marco, Teresa De; Farber, Harrison W; Gaine, Sean; Galie, Nazzareno; Krasuski, Richard A; Preston, Ioana; Souza, Rogerio de ; Coghlan, J. Gerry
Source: Chest. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, QUESTIONÁRIOS, ARTÉRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MCLAUGHLIN, Vallerie V et al. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents. Chest, v. 157, n. 4, p. 955-965, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2019.10.043. Acesso em: 09 nov. 2024.
APA
Mclaughlin, V. V., Channick, R., Marco, T. D., Farber, H. W., Gaine, S., Galie, N., et al. (2020). Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents. Chest, 157( 4), 955-965. doi:10.1016/j.chest.2019.10.043
NLM
Mclaughlin VV, Channick R, Marco TD, Farber HW, Gaine S, Galie N, Krasuski RA, Preston I, Souza R de, Coghlan JG. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents [Internet]. Chest. 2020 ; 157( 4): 955-965.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.10.043
Vancouver
Mclaughlin VV, Channick R, Marco TD, Farber HW, Gaine S, Galie N, Krasuski RA, Preston I, Souza R de, Coghlan JG. Results of an expert consensus survey on the treatment of pulmonary arterial hypertension with oral prostacyclin pathway agents [Internet]. Chest. 2020 ; 157( 4): 955-965.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.10.043
Artigo de periodico
Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis (2020)
Kawano-dourado, Leticia; Doyle, Tracy J; Bonfiglioli, Karina; Sawamura, Marcio V. Y; Nakagawa, Renato H; Arimura, Fabio E; Lee, Hye J; Rangel, Diana Arrais de Souza; Carvalho, Carlos Roberto Ribeiro de ; Kairalla, Ronaldo Adib
Source: Chest. Unidade: FM
Subjects: ENVELHECIMENTO, ARTRITE REUMATOIDE, DOENÇAS PULMONARES INTERSTICIAIS, ESTUDOS RETROSPECTIVOS, FATORES DE RISCO, TOMOGRAFIA COMPUTADORIZADA POR RAIOS X
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWANO-DOURADO, Leticia et al. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis. Chest, v. 158, n. 4, p. 1546-1554, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2020.04.061. Acesso em: 09 nov. 2024.
APA
Kawano-dourado, L., Doyle, T. J., Bonfiglioli, K., Sawamura, M. V. Y., Nakagawa, R. H., Arimura, F. E., et al. (2020). Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis. Chest, 158( 4), 1546-1554. doi:10.1016/j.chest.2020.04.061
NLM
Kawano-dourado L, Doyle TJ, Bonfiglioli K, Sawamura MVY, Nakagawa RH, Arimura FE, Lee HJ, Rangel DA de S, Carvalho CRR de, Kairalla RA. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis [Internet]. Chest. 2020 ; 158( 4): 1546-1554.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2020.04.061
Vancouver
Kawano-dourado L, Doyle TJ, Bonfiglioli K, Sawamura MVY, Nakagawa RH, Arimura FE, Lee HJ, Rangel DA de S, Carvalho CRR de, Kairalla RA. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis [Internet]. Chest. 2020 ; 158( 4): 1546-1554.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2020.04.061
Artigo de periodico-carta/editorial
Rebuttal From Drs Drager and Lorenzi-Filho [Editorial] (2019)
Drager, Luciano Ferreira; Lorenzi Filho, Geraldo
Source: Chest. Unidade: FM
Subjects: HIPERTENSÃO, PRESSÃO SANGUÍNEA, RESPIRAÇÃO COM PRESSÃO POSITIVA, APNEIA DO SONO TIPO OBSTRUTIVA, DEBATE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira e LORENZI FILHO, Geraldo. Rebuttal From Drs Drager and Lorenzi-Filho [Editorial]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2019.04.006. Acesso em: 09 nov. 2024. , 2019
APA
Drager, L. F., & Lorenzi Filho, G. (2019). Rebuttal From Drs Drager and Lorenzi-Filho [Editorial]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2019.04.006
NLM
Drager LF, Lorenzi Filho G. Rebuttal From Drs Drager and Lorenzi-Filho [Editorial] [Internet]. Chest. 2019 ; 155( 6): 1101-1102.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.04.006
Vancouver
Drager LF, Lorenzi Filho G. Rebuttal From Drs Drager and Lorenzi-Filho [Editorial] [Internet]. Chest. 2019 ; 155( 6): 1101-1102.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.04.006
Artigo de periodico
The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial (2019)
Ou, Qiong; Chen, Baixin; Loftier, Kelly A; Luo, Yuanming; Zhang, Xilong; Chen, Rui; Wang, Qian; Drager, Luciano Ferreira; Lorenzi Filho, Geraldo; Hlavac, Michael
Source: Chest. Unidade: FM
Subjects: APNEIA DO SONO TIPO OBSTRUTIVA, RESPIRAÇÃO COM PRESSÃO POSITIVA, DOENÇAS CARDIOVASCULARES, OBESIDADE, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OU, Qiong et al. The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial. Chest, v. 155, n. 4, p. 720-729, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2018.08.1082. Acesso em: 09 nov. 2024.
APA
Ou, Q., Chen, B., Loftier, K. A., Luo, Y., Zhang, X., Chen, R., et al. (2019). The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial. Chest, 155( 4), 720-729. doi:10.1016/j.chest.2018.08.1082
NLM
Ou Q, Chen B, Loftier KA, Luo Y, Zhang X, Chen R, Wang Q, Drager LF, Lorenzi Filho G, Hlavac M. The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial [Internet]. Chest. 2019 ; 155( 4): 720-729.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2018.08.1082
Vancouver
Ou Q, Chen B, Loftier KA, Luo Y, Zhang X, Chen R, Wang Q, Drager LF, Lorenzi Filho G, Hlavac M. The effects of long-term CPAP on weight change in patients with comorbid OSA and cardiovascular disease data from the SAVE Trial [Internet]. Chest. 2019 ; 155( 4): 720-729.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2018.08.1082
Artigo de periodico
OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study (2019)
Drager, Luciano Ferreira; Santos, Ronaldo B; Silva, Wagner A; Parise, Barbara K; Giatti, Soraya; Aielo, Aline N; Souza, Silvana P; Furlan, Sofia F; Lorenzi Filho, Geraldo; Lotufo, Paulo Andrade; Benseñor, Isabela Judith Martins
Source: Chest. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, APNEIA DO SONO TIPO OBSTRUTIVA, FATORES DE RISCO, PRIVAÇÃO DE SONO, ESTUDOS LONGITUDINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira et al. OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study. Chest, v. 155, n. 6, p. 1190-1198, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2018.12.003. Acesso em: 09 nov. 2024.
APA
Drager, L. F., Santos, R. B., Silva, W. A., Parise, B. K., Giatti, S., Aielo, A. N., et al. (2019). OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study. Chest, 155( 6), 1190-1198. doi:10.1016/j.chest.2018.12.003
NLM
Drager LF, Santos RB, Silva WA, Parise BK, Giatti S, Aielo AN, Souza SP, Furlan SF, Lorenzi Filho G, Lotufo PA, Benseñor IJM. OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study [Internet]. Chest. 2019 ; 155( 6): 1190-1198.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2018.12.003
Vancouver
Drager LF, Santos RB, Silva WA, Parise BK, Giatti S, Aielo AN, Souza SP, Furlan SF, Lorenzi Filho G, Lotufo PA, Benseñor IJM. OSA, Short Sleep Duration, and Their Interactions With Sleepiness and Cardiometabolic Risk Factors in Adults The ELSA-Brasil Study [Internet]. Chest. 2019 ; 155( 6): 1190-1198.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2018.12.003
Artigo de periodico
Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA (2019)
Madeiro, Fernanda; Andrade, Rafaela Garcia Santos de; Piccin, Vivien Schmeling; Pinheiro, George do Lago; Moriya, Henrique Takachi ; Genta, Pedro Rodrigues; Lorenzi Filho, Geraldo
Source: Chest. Unidades: EP, FM
Subjects: APNEIA DO SONO TIPO OBSTRUTIVA, RESPIRAÇÃO COM PRESSÃO POSITIVA, RESPIRAÇÃO ORO-NASAL, POLISSONOGRAFIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MADEIRO, Fernanda et al. Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA. Chest, v. 156, n. 6, p. 1187-1194, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2019.05.024. Acesso em: 09 nov. 2024.
APA
Madeiro, F., Andrade, R. G. S. de, Piccin, V. S., Pinheiro, G. do L., Moriya, H. T., Genta, P. R., & Lorenzi Filho, G. (2019). Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA. Chest, 156( 6), 1187-1194. doi:10.1016/j.chest.2019.05.024
NLM
Madeiro F, Andrade RGS de, Piccin VS, Pinheiro G do L, Moriya HT, Genta PR, Lorenzi Filho G. Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA [Internet]. Chest. 2019 ; 156( 6): 1187-1194.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.05.024
Vancouver
Madeiro F, Andrade RGS de, Piccin VS, Pinheiro G do L, Moriya HT, Genta PR, Lorenzi Filho G. Transmission of Oral Pressure Compromises Oronasal CPAP Efficacy in the Treatment of OSA [Internet]. Chest. 2019 ; 156( 6): 1187-1194.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.05.024
Artigo de periodico
Patients with OSA are perceived as younger following treatment with CPAP (2019)
Yagihara, Fabiana; Lorenzi Filho, Geraldo ; Santos-Silva, Rogerio
Source: Chest. Unidade: FM
Subjects: APNEIA DO SONO TIPO OBSTRUTIVA, PLACEBOS, RESPIRAÇÃO COM PRESSÃO POSITIVA, APARÊNCIA FÍSICA, ENSAIO CLÍNICO, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YAGIHARA, Fabiana e LORENZI FILHO, Geraldo e SANTOS-SILVA, Rogerio. Patients with OSA are perceived as younger following treatment with CPAP. Chest, v. 156, n. 3, p. 553-561, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.chest.2019.03.015. Acesso em: 09 nov. 2024.
APA
Yagihara, F., Lorenzi Filho, G., & Santos-Silva, R. (2019). Patients with OSA are perceived as younger following treatment with CPAP. Chest, 156( 3), 553-561. doi:10.1016/j.chest.2019.03.015
NLM
Yagihara F, Lorenzi Filho G, Santos-Silva R. Patients with OSA are perceived as younger following treatment with CPAP [Internet]. Chest. 2019 ; 156( 3): 553-561.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.03.015
Vancouver
Yagihara F, Lorenzi Filho G, Santos-Silva R. Patients with OSA are perceived as younger following treatment with CPAP [Internet]. Chest. 2019 ; 156( 3): 553-561.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.03.015
Artigo de periodico-carta/editorial
POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial] (2019)
Drager, Luciano Ferreira; Lorenzi Filho, Geraldo
Source: Chest. Unidade: FM
Subjects: HIPERTENSÃO, PRESSÃO SANGUÍNEA, TRANSTORNOS DO SONO, RESPIRAÇÃO COM PRESSÃO POSITIVA, QUESTIONÁRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira e LORENZI FILHO, Geraldo. POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2019.04.008. Acesso em: 09 nov. 2024. , 2019
APA
Drager, L. F., & Lorenzi Filho, G. (2019). POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial]. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2019.04.008
NLM
Drager LF, Lorenzi Filho G. POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial] [Internet]. Chest. 2019 ; 155( 6): 1095-1097.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.04.008
Vancouver
Drager LF, Lorenzi Filho G. POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? yes [Editorial] [Internet]. Chest. 2019 ; 155( 6): 1095-1097.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2019.04.008
Artigo de periodico-carta/editorial
Building the Future of Trial Design in PAH on Solid Ground (2018)
Souza, Rogerio
Source: Chest. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogerio. Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.chest.2018.01.041. Acesso em: 09 nov. 2024. , 2018
APA
Souza, R. (2018). Building the Future of Trial Design in PAH on Solid Ground. Chest. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.chest.2018.01.041
NLM
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
Vancouver
Souza R. Building the Future of Trial Design in PAH on Solid Ground [Internet]. Chest. 2018 ; 153( 5): 1089-1090.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.chest.2018.01.041
Trabalho de evento-resumo periodico
Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy (2013)
Simonneau, Gérald; Channick, Richard; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein; Jansa, Pavel; Le Brun, Franck - Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomas; Sastry, B.; Sitbon, Olivier; Torbicki, Adam; Rubin, Lewis
Source: Chest. Conference titles: CHEST 2013 Annual Meeting Abstracts. Unidade: FM
Subjects: PROGNÓSTICO, HIPERTENSÃO PULMONAR (TERAPIA), FATORES DE RISCO, FÁRMACOS (SISTEMA RESPIRATÓRIO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMONNEAU, Gérald et al. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3. Acesso em: 09 nov. 2024. , 2013
APA
Simonneau, G., Channick, R., Delcroix, M., Galiè, N., Ghofrani, H., Jansa, P., et al. (2013). Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.1701395
NLM
Simonneau G, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy [Internet]. Chest. 2013 ; 144( 4): 876A.[citado 2024 nov. 09 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Vancouver
Simonneau G, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L. Effect of Macitentan on Long-term Outcomes in Patients With Pulmonary Arterial Hypertension (PAH): Subanalysis of SERAPHIN Comparing Incident and Prevalent Patient Populations Not Treated With Background PAH-Specific Therapy [Internet]. Chest. 2013 ; 144( 4): 876A.[citado 2024 nov. 09 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Trabalho de evento-resumo periodico
Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan (2013)
Channick, Richard; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein A.; Jansa, Pavel; Le Brun, Franck - Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomas; Souza, Rogério; Sastry, B.; Sitbon, Olivier; Torbicki, Adam; Rubin, Lewis; Simonneau, Gérald
Source: Chest. Conference titles: CHEST 2013 Annual Meeting Abstracts. Unidade: FM
Subjects: ESTUDOS RANDOMIZADOS, HIPERTENSÃO PULMONAR, FATORES DE RISCO, FÁRMACOS (SISTEMA RESPIRATÓRIO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHANNICK, Richard et al. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3. Acesso em: 09 nov. 2024. , 2013
APA
Channick, R., Delcroix, M., Galiè, N., Ghofrani, H. A., Jansa, P., Le Brun, F. -O., et al. (2013). Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.1701395
NLM
Channick R, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Souza R, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 870B.[citado 2024 nov. 09 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Vancouver
Channick R, Delcroix M, Galiè N, Ghofrani HA, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Souza R, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Do Parameters of Cardiac Function Predict Long-term Outcomes in Patients With Pulmonary Arterial Hypertension? Data From SERAPHIN, a Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 870B.[citado 2024 nov. 09 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Trabalho de evento-resumo periodico
Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan (2013)
Souza, Rogério; Channick, Richard; Delcroix, Marion; Galiè, Nazzareno; Ghofrani, Hossein; Jansa, Pavel; Le Brun, Franck - Olivier; Mehta, Sanjay; Perchenet, Loic; Pulido, Tomas; Sastry, B.; Sitbon, Olivier; Torbicki, Adam; Rubin, Lewis; Simonneau, Gérald
Source: Chest. Conference titles: CHEST 2013 Annual Meeting Abstracts. Unidade: FM
Subjects: PROGNÓSTICO, HIPERTENSÃO PULMONAR, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Rogério et al. Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3. Acesso em: 09 nov. 2024. , 2013
APA
Souza, R., Channick, R., Delcroix, M., Galiè, N., Ghofrani, H., Jansa, P., et al. (2013). Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan. Chest. Chicago: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.1701714
NLM
Souza R, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 879A.[citado 2024 nov. 09 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Vancouver
Souza R, Channick R, Delcroix M, Galiè N, Ghofrani H, Jansa P, Le Brun F-O, Mehta S, Perchenet L, Pulido T, Sastry B, Sitbon O, Torbicki A, Rubin L, Simonneau G. Association Between WHO Functional Class and Long-term Prognosis in Patients With Pulmonary Arterial Hypertension: Data From SERAPHIN, A Randomized Controlled Study of Macitentan [Internet]. Chest. 2013 ; 144( 4): 879A.[citado 2024 nov. 09 ] Available from: http://journal.publications.chestnet.org/solr/searchresults.aspx?q=rog%C3%A9rio%20souza&allJournals=1&restypeid=3
Artigo de periodico
Proinflammatory and Antiinflammatory Cytokine Levels in Complicated and Noncomplicated Parapneumonic Pleural Effusions (2012)
Marchi, Evaldo; Vargas, Francisco S.; Acencio, Milena M.; Sigrist, Rosa M. S.; Biscaro, Marjourie D. A.; Antonangelo, Leila; Teixeira, Lisete R.; Light, Richard W.
Source: Chest. Unidade: FM
Subjects: INFLAMAÇÃO, PNEUMONIA (DIAGNÓSTICO;IMUNOLOGIA), PLEURA (IMUNOLOGIA), CITOCINAS, CÉLULAS ENDOTELIAIS, ANTI-INFLAMATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCHI, Evaldo et al. Proinflammatory and Antiinflammatory Cytokine Levels in Complicated and Noncomplicated Parapneumonic Pleural Effusions. Chest, v. 141, n. 1, p. 183-189, 2012Tradução . . Disponível em: https://doi.org/10.1378/chest.10-3181. Acesso em: 09 nov. 2024.
APA
Marchi, E., Vargas, F. S., Acencio, M. M., Sigrist, R. M. S., Biscaro, M. D. A., Antonangelo, L., et al. (2012). Proinflammatory and Antiinflammatory Cytokine Levels in Complicated and Noncomplicated Parapneumonic Pleural Effusions. Chest, 141( 1), 183-189. doi:10.1378/chest.10-3181
NLM
Marchi E, Vargas FS, Acencio MM, Sigrist RMS, Biscaro MDA, Antonangelo L, Teixeira LR, Light RW. Proinflammatory and Antiinflammatory Cytokine Levels in Complicated and Noncomplicated Parapneumonic Pleural Effusions [Internet]. Chest. 2012 ; 141( 1): 183-189.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1378/chest.10-3181
Vancouver
Marchi E, Vargas FS, Acencio MM, Sigrist RMS, Biscaro MDA, Antonangelo L, Teixeira LR, Light RW. Proinflammatory and Antiinflammatory Cytokine Levels in Complicated and Noncomplicated Parapneumonic Pleural Effusions [Internet]. Chest. 2012 ; 141( 1): 183-189.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1378/chest.10-3181
Artigo de periodico
The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension (2012)
Fernandes, Caio J. C. S.; Dias, Bruno A.; Jardim, Carlos V. P.; Hovnanian, Andre; Hoette, Susana; Morinaga, Luciana K.; Souza, Silvia; Suesada, Milena; Breda, Ana P.; Souza, Rogério
Source: Chest. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, ESQUISTOSSOMOSE (TERAPIA), HEMODINÂMICA, ANTICOAGULANTES (EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Caio J. C. S. et al. The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension. Chest, v. 141, n. 4, p. 923-928, 2012Tradução . . Disponível em: https://doi.org/10.1378/chest.11-0483. Acesso em: 09 nov. 2024.
APA
Fernandes, C. J. C. S., Dias, B. A., Jardim, C. V. P., Hovnanian, A., Hoette, S., Morinaga, L. K., et al. (2012). The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension. Chest, 141( 4), 923-928. doi:10.1378/chest.11-0483
NLM
Fernandes CJCS, Dias BA, Jardim CVP, Hovnanian A, Hoette S, Morinaga LK, Souza S, Suesada M, Breda AP, Souza R. The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension [Internet]. Chest. 2012 ; 141( 4): 923-928.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1378/chest.11-0483
Vancouver
Fernandes CJCS, Dias BA, Jardim CVP, Hovnanian A, Hoette S, Morinaga LK, Souza S, Suesada M, Breda AP, Souza R. The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension [Internet]. Chest. 2012 ; 141( 4): 923-928.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1378/chest.11-0483
Artigo de periodico
Exhaled Acetone as a New Biomarker of Heart Failure Severity (2012)
Braga, Fabiana G. Marcondes; Gutz, Ivano Gebhardt Rolf ; Batista, Guilherme L.; Saldiva, Paulo Hilário Nascimento ; Ferreira, Silvia M. Ayub; Issa, Victor S.; Mangini, Sandrigo; Bocchi, Edimar A.; Bacal, Fernando
Source: Chest. Unidades: FM, IQ
Subjects: INSUFICIÊNCIA CARDÍACA (DIAGNÓSTICO), BIOMARCADORES (CLASSIFICAÇÃO), PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Fabiana G. Marcondes et al. Exhaled Acetone as a New Biomarker of Heart Failure Severity. Chest, v. 142, n. 2, p. 457-466, 2012Tradução . . Disponível em: http://journal.publications.chestnet.org/data/Journals/CHEST/24699/457.pdf. Acesso em: 09 nov. 2024.
APA
Braga, F. G. M., Gutz, I. G. R., Batista, G. L., Saldiva, P. H. N., Ferreira, S. M. A., Issa, V. S., et al. (2012). Exhaled Acetone as a New Biomarker of Heart Failure Severity. Chest, 142( 2), 457-466. doi:10.1378/chest.11-2892
NLM
Braga FGM, Gutz IGR, Batista GL, Saldiva PHN, Ferreira SMA, Issa VS, Mangini S, Bocchi EA, Bacal F. Exhaled Acetone as a New Biomarker of Heart Failure Severity [Internet]. Chest. 2012 ; 142( 2): 457-466.[citado 2024 nov. 09 ] Available from: http://journal.publications.chestnet.org/data/Journals/CHEST/24699/457.pdf
Vancouver
Braga FGM, Gutz IGR, Batista GL, Saldiva PHN, Ferreira SMA, Issa VS, Mangini S, Bocchi EA, Bacal F. Exhaled Acetone as a New Biomarker of Heart Failure Severity [Internet]. Chest. 2012 ; 142( 2): 457-466.[citado 2024 nov. 09 ] Available from: http://journal.publications.chestnet.org/data/Journals/CHEST/24699/457.pdf
Artigo de periodico
Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions (2011)
Cartaxo, Ana Maria; Vargas, Francisco S.; Salge, João Marcos; Marcondes, Bianca F.; Genofre, Eduardo H.; Antonangelo, Leila; Marchi, Evaldo; Teixeira, Lisete R.
Source: Chest. Unidade: FM
Subjects: DERRAME PLEURAL, TESTES RESPIRATÓRIOS, SEGUIMENTOS, CAPACIDADE PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARTAXO, Ana Maria et al. Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions. Chest, v. 139, p. 1424-1429, 2011Tradução . . Disponível em: http://chestjournal.chestpubs.org/content/139/6/1424.full. Acesso em: 09 nov. 2024.
APA
Cartaxo, A. M., Vargas, F. S., Salge, J. M., Marcondes, B. F., Genofre, E. H., Antonangelo, L., et al. (2011). Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions. Chest, 139, 1424-1429. Recuperado de http://chestjournal.chestpubs.org/content/139/6/1424.full
NLM
Cartaxo AM, Vargas FS, Salge JM, Marcondes BF, Genofre EH, Antonangelo L, Marchi E, Teixeira LR. Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions [Internet]. Chest. 2011 ; 139 1424-1429.[citado 2024 nov. 09 ] Available from: http://chestjournal.chestpubs.org/content/139/6/1424.full
Vancouver
Cartaxo AM, Vargas FS, Salge JM, Marcondes BF, Genofre EH, Antonangelo L, Marchi E, Teixeira LR. Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions [Internet]. Chest. 2011 ; 139 1424-1429.[citado 2024 nov. 09 ] Available from: http://chestjournal.chestpubs.org/content/139/6/1424.full
Artigo de periodico-carta/editorial
Predicting Survival in Pulmonary Arterial Hypertension [Editorial]: Time to Combine Markers (2011)
Humbert, Marc; Montani, David; Souza, Rogério
Source: Chest. Unidade: FM
Subjects: BIOMARCADORES, HIPERTENSÃO PULMONAR (TERAPIA), PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HUMBERT, Marc e MONTANI, David e SOUZA, Rogério. Predicting Survival in Pulmonary Arterial Hypertension [Editorial]: Time to Combine Markers. Chest. Park Ridge: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1378/chest.10-2868. Acesso em: 09 nov. 2024. , 2011
APA
Humbert, M., Montani, D., & Souza, R. (2011). Predicting Survival in Pulmonary Arterial Hypertension [Editorial]: Time to Combine Markers. Chest. Park Ridge: Faculdade de Medicina, Universidade de São Paulo. doi:10.1378/chest.10-2868
NLM
Humbert M, Montani D, Souza R. Predicting Survival in Pulmonary Arterial Hypertension [Editorial]: Time to Combine Markers [Internet]. Chest. 2011 ; 139( 6): 1263-1264.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1378/chest.10-2868
Vancouver
Humbert M, Montani D, Souza R. Predicting Survival in Pulmonary Arterial Hypertension [Editorial]: Time to Combine Markers [Internet]. Chest. 2011 ; 139( 6): 1263-1264.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1378/chest.10-2868
Artigo de periodico
Adenopathy and pulmonary infiltrates in a japanese emigrant in Brazil (2011)
Kawassaki, Alexandre M; Haga, Hironori; Dantas, Thiago C. A; Musolino, Rafael S; Baldi, Bruno G; Carvalho, Carlos Roberto Ribeiro De; Kairalla, Ronaldo Adib; Mauad, Thais
Source: Chest. Unidade: FM
Subjects: DOENÇAS PULMONARES INTERSTICIAIS, DISPNEIA, DIABETES MELLITUS, AUTOIMUNIDADE, ANTICORPOS, EMIGRANTES, JAPONESES, MULHERES, TESTES DE FUNÇÃO RESPIRATÓRIA, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWASSAKI, Alexandre M et al. Adenopathy and pulmonary infiltrates in a japanese emigrant in Brazil. Chest, v. 139, n. 4, p. 947-952, 2011Tradução . . Disponível em: https://doi.org/10.1378/chest.10-0632. Acesso em: 09 nov. 2024.
APA
Kawassaki, A. M., Haga, H., Dantas, T. C. A., Musolino, R. S., Baldi, B. G., Carvalho, C. R. R. D., et al. (2011). Adenopathy and pulmonary infiltrates in a japanese emigrant in Brazil. Chest, 139( 4), 947-952. doi:10.1378/chest.10-0632
NLM
Kawassaki AM, Haga H, Dantas TCA, Musolino RS, Baldi BG, Carvalho CRRD, Kairalla RA, Mauad T. Adenopathy and pulmonary infiltrates in a japanese emigrant in Brazil [Internet]. Chest. 2011 ; 139( 4): 947-952.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1378/chest.10-0632
Vancouver
Kawassaki AM, Haga H, Dantas TCA, Musolino RS, Baldi BG, Carvalho CRRD, Kairalla RA, Mauad T. Adenopathy and pulmonary infiltrates in a japanese emigrant in Brazil [Internet]. Chest. 2011 ; 139( 4): 947-952.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1378/chest.10-0632

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Funding Agencies